Immunocore Holdings plc Share Price

Immunocore Holdings plc Share Price

NASDAQ: IMCR | Small Cap
$31.31
-$1.40 (-4.28%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Immunocore Holdings plc Stock Performance

Open
$32.33
Prev. Close
$32.71
Circuit Range
N/A
Day Range
$31.24 - $32.33
Year Range
$27.58 - $40.40
Volume
15,814
Average Traded
$31.69

Immunocore Holdings plc Share Price Today

As of 30 October 2026, Immunocore Holdings plc's share price is $31.31. The stock opened at $32.33, compared to its previous close of $32.71. During today's trading session, Immunocore Holdings plc's share price traded between $31.24 and $32.33, with an average price of $31.78. Over the past 52 weeks, the stock has recorded a high of $40.40 and a low of $27.58. In terms of performance, Immunocore Holdings plc's share price has risen by 11.74% over the last six months and is down 4.91% on a year-on-year basis.

Immunocore Holdings plc Share Price Chart

Line chart of the Immunocore Holdings plc price trend over the selected period. The price fell overall, ranging from 31.25 to 32.33, ending at 31.31.
$31.24$32.33
L
Show Current Price
H

Immunocore Holdings plc Stock Fundamentals & Key Indicators

Market Cap
$1.58B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.35
Revenue (TTM)
$400.02B
Return On Equity (TTM)
-4.31%
Profit Margin
-8.88%
Debt to Equity
0.94
Quarterly Earnings Growth YoY
-350.00%

Immunocore Holdings plc Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$103.69$104.48$106.68$115.93
Net Profit-$0.18-$30.06$12.97-$0.81
Net Profit Margin-0.17%-28.77%12.16%-0.70%
Income ChangeN/A-16600.00%143.15%-106.25%

Immunocore Holdings plc Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$174.36$249.43$310.20$400.02
Net Profit-$52.54-$55.29-$51.09-$35.51
Net Profit Margin-30.13%-22.17%-16.47%-8.88%
Income ChangeN/A-5.23%7.60%30.50%

About Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Immunocore Holdings plc Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$30.27
$31.33
+3.45%
Sep 2026
$35.85
$30.29
-17.65%
Aug 2026
$33.91
$36.77
+8.82%
Jul 2026
$31.88
$33.80
+6.47%
Jun 2026
$28.29
$31.74
+10.09%
May 2026
$27.72
$28.83
+2.89%
Apr 2026
$31.02
$28.02
-7.00%
Mar 2026
$31.93
$30.13
-6.83%
Feb 2026
$32.29
$32.34
-0.64%
Jan 2026
$34.62
$32.55
-5.98%
Dec 2025
$39.00
$34.62
-12.02%
Nov 2025
$32.81
$39.35
+19.51%

IMCR Share Price FAQs